Alia Therapeutics

Alia Therapeutics, the first Italian CRISPR-company, is developing innovative therapeutic approaches to defeat previously incurable genetic diseases. Alia's genome editing technology enables the modification of cellular genomes with unprecedented specificity, coupled with safe and efficient delivery to target cells.